October 20, 2020

Whole Exome Sequencing Market – Latest Innovations Drivers Dynamics And Strategic Analysis Challenges By 2027

The Global Whole Exome Sequencing Market is anticipated to upsurge till USD 3,963.14 Million by 2027 with CAGR of over 15% within 2020-2027.

Whole exome sequencing is referred to as the target genomic sequencing technique used for coding the exons, a region which can be transcribed and translated in order to express the proteins. It is used in gene discovery of the rare and complex diseases for accurate disease diagnosis and to prevent medical complications. Exome sequencing possess superior ability to diagnose exomic variation profile through single assay. It is extensively used in clinical diagnostics and therapeutic purpose along with research & drug development activities dedicated for cancer, single gene diseases, autoimmune disease and many other diseases.

Whole Exome Sequencing Market: Drivers & Opportunity

Market Driver:

  • Growing Prevalence of Cancer and Genetic Diseases

Exome sequencing is used for accurate disease diagnosis for minimizing the mortality rate. Exome sequencing guides regarding the information related to mutation within the gene leading to tumor progression or suppression. Next generation sequencing is used for diagnosing cancer, a prominent cause of death globally. Increasing prevalence of cancer, which is responsible for death of 6 million people in 2018, is driving demand for effective diagnostic technique. In addition to this, growing prevalence of single gene disorder is acting as driving force for growth of whole exome sequencing.

Get Sample Copy of This Report @ https://www.forencisresearch.com/whole-exome-sequencing-market-sample-pdf/

  • Low Cost of Whole Exome Sequencing

Whole Genome Sequencing determines complete DNA sequencing escalating the overall cost of the sequencing procedure. However, the exome sequencing code is only for the exon portion, which applies next-generation technology for determination variation of exome. Due to this, it reduces the overall sequencing cost and offers rapid diagnosis in order to detect mutations and indel in the region. Due to relatively low cost of exome sequencing, the market is expected to grow in the years to follow.

Market Restraint:

  • Dependence on Regulatory Approvals

Whole exome sequencing technique has emerged as novel technique in detection of gene mutations leading to genetic diseases. However, higher dependence on the regulatory authorities such as Food and Drug Administration (FDA) hinders the market growth. The guidelines set by FDA includes certain considerations regarding design, production and validation of the exome sequencing, hampers launch of new products by the potential market players, which in turn hinders the market growth

Whole Exome Sequencing Market: Key Segments

  • By Type, the market is segmented into: Product and Service
  • By Application, the market is segmented into: Clinical Diagnostic, Drug Discovery and Academic Research
  • By Geography, the market is segmented into: North America, South America, Europe, Asia-Pacific, Middle East & Africa and South America, with individual country-level analysis.

Request for Methodology of This Report @ https://www.forencisresearch.com/whole-exome-sequencing-market-request-methodology/

Whole Exome Sequencing Market: Report Scope

The report on the whole exome sequencing market covers a deep dive analysis of historic, recent and current market trends. Furthermore, market share/ranking analysis of key players, market dynamics, competition landscape, country-wise analysis for each region covered and the entire supply chain dynamics are covered through the below segmentation.

Key Companies Covered

  • Agilent Technologies, Inc. (Company Description, Company Overview, Product Synopsis, Key Developments, SWOT Analysis)
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • BGI
  • PerkinElmer Inc.
  • 10x Genomics
  • Pacific Biosciences of California, Inc.
  • GENEWIZ, Inc.
  • Other Key Companies
    • Blueprint Genetics Oy
    • Macrogen, Inc.
    • QIAGEN
    • Eurofins Genomics

Consult with Analyst @ https://www.forencisresearch.com/whole-exome-sequencing-market-consult-with-an-analyst/

Whole Exome Sequencing Market: Report Segmentation

For the scope of the report, In-depth segmentation is offered by Forencis Research

Whole Exome Sequencing Market, by Type

  • Product
    • Instrument and Equipment
    • Kits
      • Library Quantification Kits
      • Target Enrichment Kits
      • Sample QC Kits
      • Others
    • Software
  • Service

Whole Exome Sequencing Market, by Application

  • Clinical Diagnostic
    • Oncology
    • Single-gene Disorder
    • Others
  • Drug Discovery
  • Academic Research

Whole Exome Sequencing Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Purchase this Premium Industry Research Report with Analysis @ https://www.forencisresearch.com/whole-exome-sequencing-market-purchase-now/

Table of Content

    1. Research Objectives
    2. Market Definition
    3. Research Scope
    4. Regional Coverage
    5. Research Timeline
    6. Assumptions
    7. Limitations
    1. Introduction
    2. Primary Research
      1. Key Industry Expert Insight
    3. Secondary Research
      1. Vital Data from Secondary Sources
    4. Market Size Estimation
    5. Data Validation & Triangulation
    1. Introduction
    2. Drivers
      1. Growing Prevalence of Genetic Diseases
      2. Low Cost of Whole Exome Sequencing
      3. Rising Preference for Personalized Medicine
    3. Restraint
      1. Dependence on Regulatory Approvals
      2. Lack of Skilled Professionals
    4. Opportunities
      1. Rise in Funding for Whole Exome Sequencing projects
    5. Challenges
      1. Technical and Implementation Challenges
    1. Introduction
      1. Power of Buyers
      2. Power of Suppliers
      3. Intensity of Competition
      4. Challenges of Substitutes
      5. Challenges of New Entrants
    2. Macro-Economic Indicators
  6. GLOBAL WHOLE EXOME SEQUENCING MARKET BY TYPE, Market Size in USD Million (2019-2027)
    1. Introduction
    2. Product
      1. Instrument and Equipment
      2. Kits
        1. Library Quantification Kits
        2. Target Enrichment Kits
        3. Sample QC Kits
        4. Others
      3. Software
    3. Service
    1. Introduction
    2. Clinical Diagnostic
      1. Oncology
      2. Single-gene Disorder
      3. Others
    3. Drug Discovery
    4. Academic Research
    1. North America
      1. US
      2. Canada
      3. Mexico
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Asia-Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of Asia-Pacific
    4. Middle East and Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of Middle East and Africa
    5. South America
      1. Brazil
      2. Argentina
      3. Rest of South America
    1. Introduction
    2. Market Ranking/Share Analysis of Key Companies
    3. Company Benchmarking
    1. Agilent Technologies, Inc.
      1. Company Overview
      2. Financial Overview
      3. Products/Solutions/Services Offered
      4. Key Developments
      5. SWOT Analysis
    2. Thermo Fisher Scientific Inc.
    3. Illumina, Inc.
    4. F. Hoffmann-La Roche Ltd
    5. BGI
    6. PerkinElmer Inc.
    7. 10x Genomics
    8. Pacific Biosciences of California, Inc.
    9. GENEWIZ, Inc.
    10. Other Key Companies
      1. CENTOGENE N.V.
      2. Blueprint Genetics Oy
      3. Macrogen, Inc.
      4. QIAGEN
      5. Eurofins Genomics
    1. Key Industry Expert Insights
    2. Primary Discussion Guide
    3. Customization Options

Purchase this Premium Industry Research Report with Analysis @ https://www.forencisresearch.com/whole-exome-sequencing-market-purchase-now/

About Forencis Research

Forencis Research is a B2B market research, intelligence and advisory firm engaging in market research and consulting services across leading industries, globally. Our robust and meticulous research team provides high growth and niche syndicated reports, customized reports and consulting reports to the diverse global fortune clientele and intellectual institutions. Forencis Research database is a constantly evolving pool of reports and white paper studies which helps companies to foster accelerated revenue growth in global and regional markets. Forencis Research delivers market research and consulting reports on high growth markets to help companies dominate their competition and set themselves apart by attaining increased revenue growth. To enable exclusive insights around the target market, Forencis Research employs robust research Methodology & Design which includes data acquisition, data synthesis and data correlation, through Primary and Secondary Research. Through the obtained data, Top-down and bottom-up methods are exercised to attain and verify data sanity within the entire market. This market data is yet again correlated with Forencis Research’s internal database before presenting it in any of our final publications. These methods of data correlation and amalgamation benefit us to put forward accurate market estimates enabling our clients to transform their business, markets and most importantly their “REVENUES”.

Contact Us


Phone: +1 (720) 306 9020

Email: sales@forencisresearch.com

For more market research insights, please visit https://www.forencisresearch.com